h1

h2

h3

h4

h5
h6

001     982586
005     20250508050816.0
024 7 _ |a eva552842
|2 HSB
024 7 _ |a 0887-6924
|2 ISSN
024 7 _ |a 1476-5551
|2 ISSN
024 7 _ |a SCOPUS:2-s2.0-85178256217
|2 SCOPUS
024 7 _ |a WOS:001109383900001
|2 WOS
024 7 _ |a 10.1038/s41375-023-02080-y
|2 doi
024 7 _ |a pmid:38007586
|2 pmid
024 7 _ |a 10.18154/RWTH-CONV-252649
|2 datacite_doi
037 _ _ |a RWTH-CONV-252649
041 _ _ |a English
100 1 _ |a Rosti, Gianantonio
|b 0
|e Corresponding author
245 _ _ |a Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study
|h online, print
260 _ _ |a London
|b Springer Nature
|c 2024
260 _ _ |c 2023
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
500 _ _ |a Published: 25 November 2023
591 _ _ |a Germany
591 _ _ |a Italy
591 _ _ |a Norway
591 _ _ |a Peoples R China
591 _ _ |a Spain
591 _ _ |a UK
591 _ _ |a USA
700 1 _ |0 P:(DE-82)IDM06025
|a Brümmendorf, Tim Henrik
|b 1
|u rwth
700 1 _ |a Gjertsen, Björn T.
|b 2
700 1 _ |a Giraldo-Castellano, Pilar
|b 3
700 1 _ |a Castagnetti, Fausto
|b 4
700 1 _ |a Gambacorti-Passerini, Carlo
|b 5
700 1 _ |a Ernst, Thomas
|b 6
700 1 _ |a Zhao, Huadong
|b 7
700 1 _ |a Kuttschreuter, Luke
|b 8
700 1 _ |a Purcell, Simon
|b 9
700 1 _ |a Giles, Francis J.
|b 10
700 1 _ |a Hochhaus, Andreas
|b 11
773 _ _ |0 PERI:(DE-600)2008023-2
|a 10.1038/s41375-023-02080-y
|n 1
|p 126-135
|t Leukemia : normal and malignant hemopoiesis
|v 38
|x 1476-5551
856 4 _ |u https://publications.rwth-aachen.de/record/982586/files/982586.pdf
|y OpenAccess
909 C O |o oai:publications.rwth-aachen.de:982586
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM06025
|a RWTH Aachen
|b 1
|k RWTH
914 1 _ |y 2023
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-23
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LEUKEMIA : 2022
|d 2023-08-23
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-08-23
|w ger
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b LEUKEMIA : 2022
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-23
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-23
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-23
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-23
920 1 _ |0 I:(DE-82)531040-2_20140620
|k 531040-2
|l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)
|x 0
970 _ _ |a eva552842
980 _ _ |a I:(DE-82)531040-2_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21